M. Sarpong-Duah

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

Y. Amoako, P. Saunderson, F. Sarfo, 2020, The Lancet.

Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay

F. Sarfo, G. Bretzel, K. Abass, 2017, PLoS neglected tropical diseases.

Natural antioxidants attenuate mycolactone toxicity to RAW 264.7 macrophages

L. Mosi, M. Sarpong-Duah, J. Adjimani, 2021, Experimental biology and medicine.

Variable Number Tandem Repeat Profiling of Mycobacterium ulcerans Reveals New Genotypes in Buruli Ulcer Endemic Communities in Ghana and Côte d’Ivoire

L. Mosi, M. Sarpong-Duah, Charles Quaye, 2022, Frontiers in Microbiology.

Microscopy for Acid Fast Bacilli: A Useful but Neglected Tool in Routine Laboratory Diagnosis of Buruli Ulcer

G. Bretzel, M. Frimpong, R. Phillips, 2015 .